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Themechanisms underlying human natural killer (NK)
cell phenotypic and functional heterogeneity are un-
known. Here, we describe the emergence of diverse
subsets of humanNKcells selectively lacking expres-
sion of signaling proteins after human cytomegalo-
virus (HCMV) infection. The absence of B andmyeloid
cell-related signaling protein expression in these NK
cell subsets correlated with promoter DNA hyperme-
thylation. Genome-wide DNA methylation patterns
were strikingly similar between HCMV-associated
adaptive NK cells and cytotoxic effector T cells but
differed from those of canonical NK cells. Functional
interrogation demonstrated altered cytokine respon-
siveness in adaptive NK cells that was linked to
reduced expression of the transcription factor
PLZF. Furthermore, subsets of adaptive NK cells
demonstrated significantly reduced functional re-
sponses to activated autologous T cells. The present
results uncover a spectrum of epigenetically unique
adaptive NK cell subsets that diversify in response
to viral infection and have distinct functional capabil-
ities compared to canonical NK cell subsets.
INTRODUCTION
Natural killer (NK) cells are lymphocytes that act at the interface
between innate and adaptive immunity (Vivier et al., 2011).Target-cell-mediated activation of NK cells can lead to eradica-
tion of virus-infected and neoplastic cells by directed release of
cytotoxic granules as well as production of cytokines, including
interferon-g (IFN-g) and tumor necrosis factor (TNF). Aside from
such cytotoxic and pro-inflammatory functions, NK cells can
fine-tune adaptive immune responses and maintain immune ho-
meostasis, e.g., through killing of antigen-presenting cells or
activated T cells (Crouse et al., 2014; Ferlazzo et al., 2002;
Waggoner et al., 2012; Xu et al., 2014). Additionally, NK cells pro-
duce IFN-g in response to combinations of exogenous cytokines
such as interleukin-2 (IL-2), IL-12, IL-15, and IL-18 (Caligiuri,
2008).
Unlike the activation of adaptive T and B lymphocytes, which
is dictated by somatically recombined, clonally distributed an-
tigen receptors, NK cell activation is controlled by a multitude
of activating and inhibitory germline-encoded receptors (Long
et al., 2013). Most activating NK cell receptors are expressed
on the majority of NK cells. These include NKp30, NKp46,
NKp80, signaling lymphocyte activation molecule (SLAM)
family receptors such as 2B4, CRACC, and NTB-A, as well
as DNAM-1 and NKG2D. These receptors recognize ligands
expressed on stressed, transformed, and proliferating cells
(Bryceson et al., 2006). In contrast, activating NKG2C and killer
cell immunoglobulin-like receptors (KIRs) display variegated
expression on NK cell subsets and are encoded by rapidly
evolving gene complexes (Khakoo et al., 2000; Valiante et al.,
1997). Notably, NK cell responses to receptor engagement
are remarkably heterogeneous within a donor population and
between individuals.
Developmentally, as well as at the transcriptional level, NK
cells are most closely related to cytotoxic T lymphocytes
(CTLs) (Bezman et al., 2012). Activation through T and BImmunity 42, 443–456, March 17, 2015 ª2015 Elsevier Inc. 443
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Figure 1. The Presence of NK Cell Subsets Devoid of FcεRg, SYK, and EAT-2 Expression Is Associated with Cytomegalovirus Infection
(A–F) PBMCs from healthy human blood donors were analyzed by flow cytometry.
(A) Relative median fluorescence intensity (MFI) of CD3z, ZAP-70, SAP, FcεRg, SYK, and EAT-2 expression in immune cell subsets. Data represent mean MFI
values from three donors.
(B) Expression of CD3z, ZAP-70, SAP, FcεRg, SYK, and EAT-2 in CD3–CD56dim NK cells from two representative donors.
(C) Expression of FcεRg, SYK, and EAT-2 in CD4+ T cells (filled histograms) and CD3–CD56dim NK cells (black lines) in a representative donor lacking signaling
proteins.
(D) Frequency of CD3–CD56dim NK cells expressing CD3z, ZAP-70, SAP, FcεRg, SYK, and EAT-2 from 196 healthy donors versus age of the individuals. HCMV–
(open circles) and HCMV+ (filled circles) individuals are indicated. Dotted lines indicate a threshold for outliers calculated as themean of HCMV– individuals plus 3
SD. ***p < 0.001 (Mann-Whitney test).
(legend continued on next page)
444 Immunity 42, 443–456, March 17, 2015 ª2015 Elsevier Inc.
lymphocyte antigen receptors is instigated upon phosphoryla-
tion of immunoreceptor tyrosine-based activation motif (ITAM)-
containing cytoplasmic domains and further propagated by
two different sets of structurally homologous signaling machin-
eries (Weiss and Littman, 1994). NK cells express not only
canonical T but also homologous B and myeloid cell signaling
proteins. Hypothetically, modulation of seemingly redundant
signaling protein expression could alter signaling properties
upon NK cell differentiation, thereby fine tuning activation
thresholds and effector responses.
Heterogeneity in NK cell differentiation and function is a
topic of growing interest. Among CD3–CD56dim NK cells, loss
of CD62L, acquisition of CD57, and expression of inhibitory re-
ceptors for self-major histocompatibility complex (MHC) class I
correlate with an increased capacity to degranulate and produce
cytokines upon target cell engagement (Anfossi et al., 2006;
Bjo¨rkstro¨m et al., 2010; Juelke et al., 2010). Subsets of NK cells
can also display adaptive immune features including robust
recall responses (Sun et al., 2009). In humans, infection with hu-
man cytomegalovirus (HCMV) as well as other viruses is associ-
ated with lasting expansions of NK cell subsets expressing
NKG2C or activating KIRs (Be´ziat et al., 2013; Guma´ et al.,
2004). Such expansions occur in response to acute infection or
reactivation of latent virus (Foley et al., 2012; Lopez-Verge`s
et al., 2011) and might, in the case of HCMV, provide protective
immunity (Kuijpers et al., 2008; Sun et al., 2009). At themolecular
level, however, it is not clear how surface receptor expression
and cellular responsiveness is modulated during NK cell differ-
entiation or in response to viral infection. Moreover, specific
markers of NK cells responding to infection have not been
established.
Here, we identified subsets of human NK cells selectively lack-
ing expression of B-cell- and myeloid-cell-related signaling pro-
teins along with reduced expression of the transcription factor
promyelocytic leukemia zinc finger (PLZF). Such subsets arose
in response to HCMV infection and displayed an adaptive NK
cell surface receptor phenotype. These cells exhibited altered
functional responses through activating receptors in response
to exogenous cytokine stimulation and upon co-culture with acti-
vated autologous T cells. Comparative analysis of NK cell and
CD8+ T cell subsets uncovered genome-wide epigenetic differ-
ences among NK cell subsets, with adaptive NK cell differentia-
tion paralleling that of CTLs. Given the critical importance of NK
cells in controlling herpesvirus infections (Biron et al., 1989)
and reports demonstrating an association between HCMV and
reduced leukemia relapse risk (Green et al., 2013; Ito et al.,
2013) that correlates with the expansion of adaptive NK cells (Fo-
ley et al., 2012), the findings presented here advance our under-
standing of the role of NK cells in viral immunity as well as cancer
control.(E) Relationship between the frequencies of CD3–CD56dim NK cells expressing Fc
only. The coefficient of determination (R2) and standard error of estimate (Sx,y) v
(F) Relationship between donorswith CD3–CD56dim NK cells lacking FcεRg (green
also Figure S1.
(G) PBMCs from 78 allogeneic hematopoietic cell transplant patients with a total o
FcεRg, SYK, and EAT-2 expression within the CD3–CD56dim NK cell subset at 1, 3
for HCMV reactivation, which occurs between 30 and 90 days after transplant,
(Student’s t test).RESULTS
Subsets of CD56dim NK Cells Devoid of FcεRg, SYK, and
EAT-2 Are Induced by HCMV Infection
To gain insight into mechanisms underlying heterogeneity in NK
cell responsiveness, we examined expression of homologous
pairs of the transmembrane adaptor proteins CD3z and FcεRg,
the tyrosine kinases ZAP-70 and SYK, and the intracellular adap-
tors SAP and EAT-2 in peripheral blood mononuclear cells
(PBMCs). As expected, T cells expressed CD3z, ZAP-70, and
SAP, B cells expressed SYK, myeloid cells expressed FcεRg,
SYK, and EAT-2, and NK cells expressed all six proteins
(Figure 1A). In a cohort of 196 healthy adults, subsets of
CD3–CD56dim NK cells from many individuals lacked FcεRg,
SYK, and EAT-2 expression, correlating with HCMV seroposi-
tivity but not with age or sex (Figures 1B–1D and S1). By compar-
ison, CD3z, ZAP-70, and SAP expression was unchanged
(Figures 1B–1D). Within the total CD3–CD56dim NK cell popula-
tion, the size of the CD3–CD56dimFcεRg– NK cell subset was
generally greater than the SYK– or EAT-2– subsets (Figure 1E).
In total, the lack of at least one signaling protein was observed
in 10.1% and 50.4% of HCMV-seronegative (HCMV–) and
HCMV-seropositive donors (HCMV+), respectively (Figure 1F),
suggesting HCMV-induced modulation of NK cell signaling.
HCMV infection can trigger emergence and persistence of
‘‘adaptive’’ or ‘‘memory-like’’ NK cells (Foley et al., 2012; Sun
et al., 2009). Therefore, we examined expression of FcεRg, SYK,
and EAT-2 in a cohort of hematopoietic cell transplant (HCT)
recipients of allogeneic umbilical cord blood grafts whom either
reactivated latent HCMV after transplant, were HCMV+ but did
not reactivate, or were HCMV–. HCMV reactivation, if it occurred,
was typically detected between 1 and 3months after transplanta-
tion. CD3–CD56dim NK cells from HCMV– recipients and HCMV+
individuals who did not experience HCMV reactivation were uni-
formly positive for FcεRg, SYK, and EAT-2 up to a year after trans-
plantation. However, in HCT recipients who reactivated HCMV,
significant populations of CD3–CD56dim NK cells lacking each
signaling protein were observed 6 months and 1 year after trans-
plant (Figure 1G). Thus, numerical expansion of NK cell subsets
selectively lacking B-cell- and myeloid-cell-related signaling pro-
tein expression is driven by acute HCMV infection.
Lack of FcεRg, SYK, and EAT-2 Expression Correlates
with an Adaptive NK Cell Phenotype
Latent HCMV infection is associated with imprints on NK cell sur-
face receptor expression (Be´ziat et al., 2013; Bezman et al.,
2012; Guma´ et al., 2004; Sun et al., 2009). Lack of FcεRg,
SYK, and EAT-2 in CD3–CD56dim NK cells correlated with
expression of NKG2C (Figure 2A), and the lack of FcεRg corre-
lated with significantly reduced NKp30 expression, reflecting aεRg, SYK, or EAT-2. Solid lines represent the correlation for HCMV+ individuals
alues for HCMV+ individuals are indicated.
), SYK (red), or EAT-2 (blue) expression amongHCMV+ andHCMV– donors. See
f 37 HCMV reactivation events were analyzed by flow cytometry for intracellular
, 6, and 12 months after transplant. Transplant patients were monitored weekly
by PCR for HCMV DNA copy number. *p < 0.05, **p < 0.01, and ***p < 0.001
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Figure 2. FcεRg–, SYK–, and EAT-2– NKCells
Display an Adaptive NK Cell Phenotype
(A–C) PBMCs from 196 healthy human blood do-
nors were analyzed by flow cytometry. The rela-
tionship between the frequencies of CD3–CD56dim
NK cells expressing NKG2C (A) or NKp30 (B)
versus FcεRg, SYK, and EAT-2. Solid lines repre-
sent the correlation for HCMV+ individuals only.
The coefficient of determination (R2) and standard
error of estimate (Sx,y) values for HCMV+ in-
dividuals are indicated. Relationship (C) between
donors with CD3CD56dim NK cells lacking FcεRg,
SYK, and/or EAT-2 expression (black) versus dis-
playing elevated NKG2C expression (light gray)
among HCMV+ and HCMV– donors.
(D–G) PBMCs from 15 healthy KIR haplotype A
donors were analyzed by flow cytometry.
(D–F) Percentages of CD3–CD56dim NK cells ex-
pressing DAP12-coupled receptors NKG2C and/
or KIR2DS4 (D), inhibitory NKG2A (E), or educating
KIRs without NKG2A (F). Bars indicate SD.
(G) The distributions of CD3–CD56dim NK cells
expressing specific KIRs, NKG2A, and NKG2C in
four HLA-typed individuals are shown. *p < 0.05
and ***p < 0.001 (Student’s t test).
See also Figure S2.requirement for FcεRg in NKp30 surface expression at the sin-
gle-cell level (Figures 2B and S2; Hwang et al., 2012). Of note,
increased NKG2C expression on CD3–CD56dim NK cell subsets
correlated strictly with HCMV+, whereas FcεRg, SYK, or EAT-2
deficiency was also observed in a small subset of CD3–CD56dim
NK cells from HCMV– individuals (Figure 2C).
Deviations in inhibitory KIR expression have been used to
define adaptive human NK cells (Be´ziat et al., 2013). To analyze
the expression of inhibitory receptors for self-MHC and DAP12-
coupled receptors on CD3–CD56dimFcεRg– NK cells, we stained
for all KIRs on FcεRg– NK cells from MHC-genotyped donors.
The majority of CD3–CD56dimFcεRg– NK cells expressed
DAP12-coupled receptors (76 ± 23, mean ± SD; Figure 2D).
With respect to inhibitory receptors specific for MHC class I,
NKG2A expression was reduced and inhibitory self-KIR
expression was increased on CD3–CD56dimFcεRg– relative to
CD3–CD56dimFcεRg+ NK cells (15 ± 19 versus 31 ± 9 and 61 ±
32 versus 43 ± 13, respectively; Figures 2E and 2F). Within indi-
vidual donors, multiple FcεRg– subsets with distinct expression
patterns of activating NKG2C and KIRs, as well as inhibitory
NKG2A and self-KIR, were evident (Figure 2G), suggesting
distinct expansions. In summary, FcεRg–, SYK–, and EAT-2–
NK cells were heterogeneous, yet phenotypically resembled
adaptive NK cells with respect to surface receptor expression.
Thus, FcεRg, SYK, and/or EAT-2 silencing represent markers
that broadly encompass adaptive NK cells.
Adaptive FcεRg– and EAT-2– NK Cells Display Promoter
DNA Methylation
Themolecular mechanisms underlying differentiation of adaptive
NK cell subsets are not well understood (Cichocki et al., 2013). In
CD8+ T cells responding to acute viral infection, genome-wide446 Immunity 42, 443–456, March 17, 2015 ª2015 Elsevier Inc.DNA methylation remodeling accompanies acquisition of the
effector phenotype and repression of the naive cell state (Scharer
et al., 2013). In our analysis, flowcytometry plots of CD3–CD56dim
NK cells revealed bi-modal downregulations of FcεRg, SYK, and
EAT-2 (Figure 3A). FcεRg, SYK, and EAT-2 expression patterns
were variegated and stable over time (Figures 3B and S3).
Together, tri-modal expression patterns and non-synchronized
deficiencies in signaling protein expression suggested regulation
by DNA methylation-dependent processes.
To determine whether DNA methylation regulates signaling
protein expression upon differentiation of adaptive NK cells, we
sorted NK cell subsets as well as naive CD3+CD8+CD45RA+
CD57– and effector CD3+CD8+CD45RA+CD57bright T cell subsets
(i.e., CTLs) from twoHCMV+donors.GenomicDNA fromeachcell
subset was analyzed by bisulfite sequencing. Relative to early
mature CD3–CD56dimCD57– and late mature CD3–CD56dim
CD57brightEAT-2+ NK cells, adaptive CD3–CD56dimCD57bright-
EAT-2– NK cells displayed hypermethylation of the FCER1G and
SH2D1B (encoding EAT-2) promoters (Figure 3C). The methyl-
ation patterns of the FCER1G and SH2D1B promoters in the
adaptiveNKcell subsetwere similar to those of naive and effector
CD8+ T cell subsets that do not express FcεRg or EAT-2. Thus,
promoterhypermethylationprobablyexplains the lackof signaling
protein expression in subsets of adaptive NK cells and, hypothet-
ically, might reflect large-scale epigenetic changes associated
with adaptive NK cell differentiation.
Genome-wide Analyses of DNA Methylation Reveal
Parallels between Differentiation of Adaptive NK Cells
and Cytotoxic Effector T Cells
To test our hypothesis of widespread epigenetic modifica-
tions during adaptive NK cell differentiation, we examined
AB
C
Figure 3. Lack of Signaling Protein Expression in Adaptive NK Cells Is Associated with Promoter DNA Hypermethylation
(A and B) PMBCs from healthy donors were analyzed by flow cytometry. Plots depict CD57 versus signaling protein expression (A) or combinations of signaling
proteins in CD3–CD56dim NK cells (B) from representative HCMV– (donor 1) and HCMV+ (donors 2–7) donors.
(C) NK cell and T cell subsets were sorted from two HCMV+ donors. Genomic DNA from each cell subset was treated with sodium bisulfite, purified and amplified
by PCR using primers specific for the promoter regions of FCER1G and SH2D1B. PCR fragments were cloned, sequenced, and analyzed for CpG methylation
content. Each row represents one sequenced PCR clone. Open circles represent unmethylated and closed circles methylated cytosines.
See also Figure S3.genome-wide DNA methylation in NK cell and CD8+ T cell sub-
sets from HCMV+ individuals. As expected, the global methyl-
ation profiles of early and late mature EAT-2+ ‘‘canonical’’ NKcells strongly resembled each other. Adaptive EAT-2– NK cells
diverged from both early and late mature NK cells in their methyl-
ation profile, with widespread hyper- as well as hypomethylationImmunity 42, 443–456, March 17, 2015 ª2015 Elsevier Inc. 447
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Figure 4. Changes in DNA Methylation Patterns in Adaptive NK Cells Are Similar to Those in Cytotoxic T Cells
(A–C) NK and T cell subsets were sorted from four HCMV+ donors. Genomic DNA from each subset was treated with sodium bisulfite and subjected to genome-
wide DNA methylation profiling.
(A) Pseudo-color scatterplots illustrating multiple pairwise comparisons of methylation (b-value) over all probes from specific subsets in donor 10 after data
filtering and probe normalization. A b-value close to zero corresponds with no methylation, and a b-value close to 1 corresponds with full methylation.
(B) Correlation matrix of all pairwise subset comparisons.
(C) MDS analysis of DNA methylation in NK cell and T cell subsets after data filtering and normalization. Samples are color coded based on the cell type and
labeled according to the donor they were derived from (donors 8, 9, 10, and 11). Only probes with a high variability in b-values across the different cell subsets are
shown (arbitrarily set as a ratio of standard deviation over a mean greater than 0.1, n = 271,769). Dimensions 1 and 2 represent the largest source of variation
(totaling 66%).
See also Figure S4.(Figure 4A). By contrast, late mature NK cells had a methylation
profile dissimilar to that of CD8+ T cell subsets, particularly
effector T cells (Figure 4A). The methylation profile of adaptive
NK cells correlated strongly with that of effector T cells (Fig-
ure 4B). These relationships were also evident upon multidimen-
sional scaling analysis of probes with a high variability of methyl-
ation across the different populations (SD/mean > 0.1)
(Figure 4C), confirming that the variation in our data was mainly
derived from the different cell types.
As expected, probed regions in close proximity to theSH2D1B
and FCER1G transcriptional start sites (TSSs) were hyperme-
thylated in adaptive relative to canonical NK cells (Figure S4A).
Comparisons of early mature and adaptive NK cells revealed
2,372 differentially methylated regions (DMRs), with an enrich-
ment of hypomethylated regions in adaptive NK cells (Fig-
ure S4B). In contrast, comparisons of adaptive NK cells versus
effector CD8+ T cells identified only 61 DMRs, supporting
the notion of convergent differentiation of adaptive NK cells
and effector CD8+ T cells. The methylation patterns of CD3D,
CD8A, BCL11B, NCR1, NCR3, FCGR3A, and TYROBP448 Immunity 42, 443–456, March 17, 2015 ª2015 Elsevier Inc.confirmed the disparate identity of adaptive NK cells and effector
CD8+ T cells (Figures S4C and S4D).
Epigenetic Changes in DNA Methylation Regulate
Adaptive NK Cell Gene Expression
Prompted by the profound epigenetic differences in NK cell
subsets, we performed gene expression arrays comparing ca-
nonical, late mature CD3–CD56dimCD57brightNKG2A–NKG2C–
and adaptive CD3–CD56dimCD57brightNKG2A–NKG2C+ NK cells
from four selected donors where surface expression of NKG2C
marked FcεRg– cells (Figures S5A and S5B). With 2-fold modu-
lation as a cut-off, 89 upregulated and 102 downregulated genes
were identified (Figure 5A). KLRC2, KLRC3, and KLRC4 tran-
scripts encoding NKG2C isoforms were upregulated up to 52-
fold. Conversely, transcripts for FCER1G, IRS2, and PLXDC2,
which encode signaling and transmembrane proteins, were
downregulated by 92% or more. Cytokine receptor-encoding
transcripts for IL12RB2, IL18RAP, and IL2RB were also signifi-
cantly downregulated. In general, hypomethylated or hyperme-
thylated DMRs within TSS regions correlated with upregulated
A B C
D
Figure 5. Transcript Expression Analyses of Canonical and Adaptive NK Cells
(A) Microarray analyses of gene expression in sorted CD3–CD56dimCD57brightNKG2A–NKG2C– versus CD3–CD56dimCD57brightNKG2A–NKG2C+ (corresponding
to FcεRgdim/–) NK cell subsets from four HCMV+ donors. Each circle represents themean expression value of 20,364 individual genes. Genes regulatedmore than
2-fold (black circles) and more than 4-fold (filled circles) consistently among donors (p < 0.05, Student’s t test) are highlighted.
(B) Relationship between the mean change in DNA methylation values of DMRs located in the vicinity of gene TSS (comparison of CD3–CD56dimCD57–
versus CD3–CD56dimCD57brightEAT-2– NK cells) versus the corresponding mean change in gene expression (CD3–CD56dimCD57brightNKG2C– versus
CD3–CD56dimCD57brightNKG2C+ NK cells).
(C and D) DNA methylation in the vicinity of TSSs of receptors that are downregulated (C) or upregulated (D) on the surface of adaptive NK cells.
See also Figure S5.and downregulated genes, respectively (Figure 5B). In this
context, probes in the vicinity of the TSSs of CD7, KLRB1 (en-
coding CD161), and KLRC1 (encoding NKG2A) were hyperme-
thylated in adaptive NK cells, whereas probes in the vicinity of
the TSSs of CD2, ITGAL (encoding CD11a), and LILRB1 (encod-
ing CD85j) were hypomethylated (Figures 5C and 5D). Thus, both
the methylation and transcriptional data reflected the reduced
expression of CD7 and CD161 and increased expression of
CD2, CD11a, and CD85j, which was confirmed at the protein
level by flow cytometry (data not shown). This expression profile
is consistent with reported surface phenotypes of HCMV-
induced adaptive NK cells (Be´ziat et al., 2013; Guma´ et al., 2004).
Reduced Expression of PLZF Marks Adaptive NK Cells
The BTB-zinc finger (BTB-ZF) family of transcription factors can
orchestrate changes in DNA methylation (Mathew et al., 2012;
Puszyk et al., 2013). ZBTB16, encoding PLZF, was the most
highly differentially regulated of all transcription factor tran-
scripts, being downregulated by 77% in adaptive NK cells (Fig-
ure 6A). In addition, ZBTB38 transcripts were 1.8-fold upregu-
lated (Figure 6A). Accordingly, an intronic sequence in ZBTB16
was hypermethylated, and the TSS of ZBTB38 was hypomethy-
lated in adaptive NK cells (Figure 6B). Moreover, the TSSs of
ZBTB20 and ZBTB32 were hypermethylated and hypomethy-
lated, respectively. Bisulfite sequencing confirmed hypermethy-
lation of the intronic ZBTB16 sequence in adaptive NK cells
(Figure S6A). Chromatin immunoprecipitation experiments with
NK cells from HCMV donors revealed that PLZF bound the pro-
moters of the genes encoding FcεRg, SYK, and EAT-2 but not
those encoding CD3z, ZAP-70, and SAP (Figure 6C). Intracellular
flow cytometry revealed strong downregulation of PLZF expres-
sion in HCMV+ individuals (Figure 6D). FcεRg, SYK, and EAT-
2 NK cell subsets were encompassed within the PLZF NK cell
population, and PLZF NK cell subsets were consistently larger
than those individually lacking expression of FcεRg, SYK, orEAT-2 (Figures 6E–6H). Intermediate PLZF expression was
also evident in one donor, corresponding to NK cell subsets dis-
playing reduced expression of FcεRg (Figure 6E, donor 3). To
visualize heterogeneity in NK cell populations, we optimized al-
gorithms for nonlinear dimensionality reduction with stochastic
neighbor embedding capable of handling large amounts of
data from multiple individuals. These multivariate analyses of
flow cytometry data illustrated how all individuals, irrespective
of HCMV serostatus, contained a range of PLZF-expressing ca-
nonical NK cells (Figures 6I–6K). In contrast, adaptive NK cells in
HCMV+ individuals distinctively displayed uniformly reduced
PLZF expression along with unique, donor-specific signaling
protein expression patterns (Figure 6K). Of note, expression of
the transcription factors T-bet and EOMES was not altered in
adaptive NK cell subsets, whereas Helios expression could be
reduced or increased (Figures S6B–S6E). Thus, PLZF binds the
promoters of the genes encoding FcεRg, SYK, or EAT-2,
and reduced PLZF expression reliably marks adaptive NK cells
displaying a probabilistic, epigenetically regulated lack of FcεRg,
SYK, and EAT-2 expression.
Distinct Functional Capacities of Adaptive NK Cells
Having uncovered alterations in NK cell signaling and transcrip-
tion factor expression in adaptive NK cells, we sought to under-
stand the functional consequences of these findings. IFN-g pro-
duction was examined in healthy individuals with NKG2C+
adaptive NK cells where the vast majority of PLZF– NK cells
lacked FcεRg expression. In such individuals, IL-12 and IL-18
co-stimulation induced significantly less IFN-g production
by CD3–CD56dimFcεRg– NK cells relative to all other NK cell
subsets, including the CD3–CD56dimCD57+FcεRg+ NK cell
subset (Figures 7A, 7B, and S7A). IL-12 and IL-18 co-stimulation
also induced significantly less IFN-g production by CD3–
CD56dimNKG2C+FcεRg– NK cells relative to the CD3–CD56dim
NKG2C+FcεRg+ NK cell subset (Figure 7C). These resultsImmunity 42, 443–456, March 17, 2015 ª2015 Elsevier Inc. 449
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demonstrate that adaptive NK cells marked by lack of PLZF
expression represent a subset functionally distinct from other
NK cells expressing CD57 or NKG2C, but with expression of
PLZF. In NK T cells, PLZF is a key regulator of innate effector pro-
grams and promotes the expression of IL-12 and IL-18 receptors
(Gleimer et al., 2012; Mathew et al., 2012). Transcription of IL-12
(IL12RB2) and IL-18 (IL18RAP) receptor subunits was reduced
in adaptive NK cells (Figure 7D), with concomitant IL-12 and
IL-18 receptor signaling also greatly reduced (Figures 7E–7G).
Adaptive NK cells did not have an intrinsic defect in cytokine pro-
duction, as shown by the fact that the NK cells lacking FcεRg,
SYK, EAT-2, or any combination thereof displayed increased
IFN-g and TNF production in response to phorbol-12-myris-
tate-13-acetate (PMA) and ionomycin stimulation (Figures 7H
and 7I), whereas degranulation was not augmented (Figure 7J).
Thus, adaptive NK cells fail to produce IFN-g in response
to innate cytokines, yet might display augmented responses
upon target cell recognition. The latter can be explained by
observed hypomethylation of IFNG and TNF regulatory regions
(Figure S7B).
We hypothesized that altered signaling of adaptive NK cells
might impede their ability to recognized and eradicate activated
T cells. NK cells from individuals with adaptive NK cell subsets
were co-cultured with purified autologous CD4+ or CD8+
T cells unstimulated or stimulated with anti-CD3- and anti-
CD28-coated beads. Notably, degranulation by adaptive NK
cells in response to CD16 stimulation was equal to that of canon-
ical CD3–CD56dim NK cells expressing FcεRg, SYK, and EAT-2
(Figure 7L). However, in response to autologous, activated
T cells, FcεRg– or EAT-2– CD3–CD56dim NK cells manifested
significantly diminished degranulation relative to other NK cell
subsets (Figures 7K and 7L). These results suggest reduced
innate activities of adaptive NK cells subsets maintaining im-
mune homeostasis or relaying signals from innate cytokines
such as IL-12 and IL-18.
Individuals with congenital or acquired deficiencies in cellular
immune responses are susceptible to severe and prolonged
HCMV infections, and heightened antibody-dependent cellular
cytotoxcity activity inversely correlates with the severity of infec-
tion (Rook, 1988). Thus, given its importance in the control ofFigure 6. Reduced PLZF Expression Specifically Marks Adaptive NK C
(A) Fold change in gene expression of BTB-ZF transcription factors in NK cell sub
filling reflects the average overall intensity of expression for indicated transcripts
(B) BTB-ZF transcription factor DMRs. Heat maps show the DNAmethylation in di
corresponds with no methylation, and a b-value close to 1 corresponds with full
(C) ChIP analysis of PLZF and Pol II binding to the promoters of FCER1G, SH2D1
donors in two separate experiments. Fold expression values are normalized aga
(D–J) PMBCs from 196 healthy human blood donors were analyzed by flow cyto
(D and E) Plots depict PLZF expression versus expression of CD57 (D) or FcεRg, S
and HCMV+ (donors 2–7) donors.
(F–H) Plots depict the frequency of CD3–CD56dim NK cells expressing PLZF vers
196). HCMV– (open circles) and HCMV+ (filled circles) individuals are indicated. S
(I–K) Barnes-Hut t-distributed stochastic neighbor embedding (t-SNE) analysis of
and six HCMV+ donors (donors 2–7).
(I) Event density in the t-SNE field for all donors compiled together or HCMV– an
(J) Protein expression levels for single parameters in t-SNE field. Red represen
FcεRg/SYK/EAT-2 parameter was constructed post-analysis. CD7 and CD161 s
(K) Event density in the t-SNE field for CD3–CD56+ NK cells from individual donors.
border between canonical NK cell populations and adaptive NK cell populations
See also Figure S6.HCMV, we analyzed Fc receptor-dependent activation of adap-
tive NK cells. In line with responses to PMA and ionomycin,
adaptive NK cells more frequently produced IFN-g and TNF in
response to IgG-coated S2 insect cells (Figures 7M and 7N). In
contrast, degranulation was similar between adaptive NK cells
and canonical NK cells (Figure 7O). Reflecting the differing ca-
pacities of SYK and ZAP-70 to instigate ITAM-dependent
signaling, SYK– NK cells displayed weaker degranulation than
SYK+ NK cells when treated with the Src kinase inhibitor PP2
(Figure 7P). Importantly, we examined the expansion of adaptive
NK cells lacking FcεRg in response to autologous HCMV-
infected monocytes (Figures 7Q and 7R). A modest increase in
the frequency of the FcεRg– NK cell subset in response to
HCMV-infected monocytes was observed (Figure 7Q). The addi-
tion of anti-HCMV antibody accentuated this increase, driving
extensive proliferation of the FcεRg– NK cell subset (Figure 7R).
These results suggest heightened resistance of adaptive NK
cells to apoptosis during inflammatory conditions, as well as
superior proliferation upon engagement of ITAM-coupled recep-
tors. In summary, our data provide evidence for a functional
dichotomy between canonical NK cells and adaptive NK cells
in terms of regulatory function and capacity to produce cyto-
kines, survive, and proliferate in response to ITAM-dependent
activating receptor signaling.
DISCUSSION
Viral infections can induce numerical expansions of phenotypi-
cally distinct NK cell subsets, leading to the establishment of
lasting imprints on the receptor repertoire (Be´ziat et al., 2013;
Guma´ et al., 2004). Recently, Zhang et al. (2013) reported that
FcεRg– NK cells are associated with HCMV seropositivity in hu-
mans. We found that expression of not only FcεRg but also other
B and myeloid cell-related signaling proteins (SYK and EAT-2)
were stochastically silenced in NK cell populations from
HCMV+ individuals and upon HCMV reactivation in HCT recipi-
ents. Silencing correlated with promoter DNA methylation.
Such NK cells that arose in response to HCMV infection dis-
played a genome-wide methylation profile that approximated
that of CTL, maintained expression of cognate T-cell-relatedells
sets. Bars indicate the mean fold change in expression for four donors. The bar
. *p < 0.05 and **p < 0.01 (paired Student’s t test).
fferent cell subsets for a set of probes within each DMR. A b-value close to zero
methylation.
B, SYK, CD247, SH2D1A, and ZAP70 using primary NK cell lysates from three
inst input and IgG controls. Bars indicate SD.
metry.
YK, or EAT-2 (E) in CD3–CD56dim NK cells from representative HCMV– (donor 1)
us FcεRg (F), SYK (G), or EAT-2 (H). Each circle represents one individual (n =
olid lines represent the correlation for HCMV+ individuals only.
11-parametric data was performed on CD3–CD56+ NK cells from four HCMV–
d HCMV+ donors compiled separately.
ts high expression, whereas blue represents low expression. The composite
tainings were also included in the model but are not shown.
Red arrows indicate the CD56bright NK cell population, and dashed red lines the
found in HCMV+ individuals.
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signaling proteins, and had enriched expression of rapidly
evolving DAP12-coupled activating receptors.
Genome-wide DNA methylation analyses of NK cell and CD8+
T cell subsets revealed that adaptive NK cells epigenetically
approximated CD8+ effector T cells. Thus, CD8+ T cells and
adaptive NK cells appear to share pathogen-driven differentia-
tion pathways. Highlighting heterogeneity, surface phenotypes
and functional responses of virus-specific CD8+ T cells change
in a graded and stochastic rather than stepwise manner during
the induction of memory to generate a remarkable degree of
functional and phenotypic diversity even among cells of the
same origin and antigen specificity (Arsenio et al., 2014; Buch-
holz et al., 2013; Gerlach et al., 2013; Stemberger et al., 2007).
The branching points of andmolecular mechanisms that underlie
adaptive NK cell differentiation are unclear. Nfil3 is required for
normal development of mouse NK cells (Gascoyne et al.,
2009). However, recent findings reveal that HCMV infection
can nonetheless drive expansions of adaptive NK cells in
Nfil3–/– mice, bypassing an early developmental requirement
for Nfil3 (Firth et al., 2013). We observed diverse patterns of
FcεRg, SYK, and EAT-2 expression along with varied expression
of maturation markers and surface receptors in adaptive NK
cells. Stochastic expression of protocadherin genes in neurons
is regulated by the de novo DNA methyltransferase Dnmt3b
and is influenced by histone modifications and gene-specific
sequence features (Toyoda et al., 2014). Whether a similar pro-
cess is involved in stochastic regulation of genes encoding
signaling molecules in NK cells remains to be determined.Figure 7. Adaptive NK Cells Display Altered Functional Responses
(A–C) PBMCs from HCMV+ individuals with a clear correlation between PLZF and
of IL-12, IL-15, and IL-18, then stained for intracellular IFN-g and analyzed by flo
CD3–CD56bright or CD3–CD56dim subsets subdivided according to expression of
(A) Gating strategy and IFN-g expression upon IL-12 plus IL-18 stimulation in NK
(B) Frequencies of NK cells expressing IFN-g within specific subsets upon stimu
(C) The frequencies of IFN-g-expressing NK cells were quantified in CD3–CD56br
NKG2C. The frequencies of NK cells expressing IFN-g within specific subsets up
donors, and bars indicate SD.
(D) Quantitative PCR analyses of gene expression in in sorted CD3–CD56dim
(corresponding to FcεRgdim/–) NK cell subsets from four HCMV+ donors, as indic
(E) Immunoblot depicting STAT4 phoshorylation in response to IL-12 stimulation
(F and G) PBMCswere stimulated with IL-18 or left untreated, and CD3–CD56dim N
by phospho-specific flow cytometry.
(F) Contour plots show CD3–CD56dim NK cells from one representative donor.
(G) Bar graphs display frequencies of phospho-p38 MAPK+ and phospho-NF-kB
Values depict the mean of three donors, and bars indicate SD.
(H–J) PBMCswere left untreated or stimulated for 6 hr with PMA and ionomycin an
positive for (H) intracellular IFN-g, (I) intracellular TNF, or (J) surface CD107a. Va
(K and L) Purified CD4+ and CD8+ T cells were left untreated or activated with
co-cultured with resting, autologous NK cells for 6 hr. Co-incubation with P815 t
(K) Plots show CD107a surface expression versus FcεRg or EAT-2 expression o
(L) The graph depicts frequencies of CD107a-expressing NK cells according to s
(M–P) PBMCs were incubated for 6 hr with S2 cells pre-coated with increasing co
by flow cytometry. Graphs depict the frequencies of intracellular IFN-g (M), intra
lations were performed in regular medium (M–O) or medium containing 1 mM S
indicate SD.
(Q and R) Purified monocytes were mock or HCMV infected and cultured with auto
where indicated. After a total of 10 days co-culture, NK cells were stained and ana
was determined.
(Q) Frequency of FcεRg– cells among total CD3–CD56dim NK cells after co-cultur
(R) Proliferation of NK cell subsets after co-culture with monocytes, as indicated
*p < 0.05, **p < 0.01, **p < 0.001 (Wilcoxon test). Bars indicate SD. See also FigRegardless of the precise mechanism, our data suggest sto-
chastic processes, branching, and selection of adaptive NK cells
from varying stages of canonical NK cell development along a
continuum, similar to what has been reported for the generation
of CD8+ T cell diversity (Arsenio et al., 2014).
Decreased expression of the transcription factor PLZFmarked
adaptive NK cells that lacked FcεRg, SYK, and/or EAT-2 expres-
sion. PLZF is amember of the BTB-ZF transcription factor family,
which can recruit chromatin-remodeling co-factors to regulate
gene expression (Lee and Maeda, 2012). PLZF is required for
the generation and function of the NK T and gd T cell lineages
and drives innate-like effector differentiation of T cell subsets
(Kovalovsky et al., 2008; Kreslavsky et al., 2009; Savage et al.,
2008). PLZF can interact with HDAC1, DNMT, and the E3 ubiq-
uitin ligase CUL3, facilitating chromatin modifications (Mathew
et al., 2012). Our data indicate that PLZF also maintains innate-
like aspects of human NK cells, with absence of PLZF contrib-
uting to the adaptive properties of NK cells from HCMV+ individ-
uals. Several known PLZF-regulated target genes, including
IL12RB2, IL18RAP, and KLRB1 (Gleimer et al., 2012), were all
downregulated in adaptive NK cells, which lack responsiveness
to inflammatory cytokines. Despite the well-established role of
PLZF as a transcriptional repressor, PLZF directly binds to and
induces a subset of IFN-stimulated genes in NK cells (Xu et al.,
2009). Our data suggest that PLZF also induces or maintains
expression of a select group of genes encoding cytokine recep-
tor components and a subset of genes encoding signaling mol-
ecules in canonical NK cells. Notably, fewer than 5% of mouseFcεRg expression were left untreated or stimulated for 24 hr with combinations
w cytometry. The frequencies of IFN-g-expressing NK cells were quantified in
FcεRg and CD57.
cell subsets from one representative donor.
lation with cytokines.
ight or CD3–CD56dim subsets subdivided according to expression of FcεRg and
on stimulation with cytokines are presented. Values depict the mean of seven
CD57brightNKG2A–NKG2C– versus CD3–CD56dimCD57brightNKG2A–NKG2C+
ated. Bars indicate SD.
in NK cells from one representative donor.
K cell subsets were analyzed for phosphorylation of p38MAPK and NF-kB p65
+ cells in CD3–CD56dim NK cell subsets gated according to FcεRg expression.
d then analyzed by flow cytometry. Graphs show frequencies of NK cell subsets
lues depict the mean of eight donors, and bars indicate SD.
anti-CD3- and anti-CD28-coated beads for 60 hr, washed, and subsequently
arget cells with or without anti-CD16 mAb served as the control.
n CD3–CD56dim NK cells.
timulation and expression of FcεRg, SYK, and EAT-2. Bars indicate SD.
ncentrations of rabbit serum, as indicated. The cells were stained and analyzed
cellular TNF (N), or surface CD107a (O, P) expressing NK cell subsets. Stimu-
rc kinase inhibitor PP2 (P). Values depict the mean of eight donors, and bars
logous, labeled NK cells added IL-15. After 2 days, anti-HCMV IgG was added
lyzed by flow cytometry. The frequency of NK cell subsets and their proliferation
e with monocytes.
. Eight donors were used in the experiment, with mean and SD indicated.
ure S7. Results are representative of at least three independent experiments.
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NK cells express PLZF, and NK cell development appears to be
normal in Zbtb16–/– (Constantinides et al., 2014). However, our
notion is supported by studies of an individual with biallelic
ZBTB16mutations whose NK cells produced markedly elevated
amounts of IFN-g and TNF upon engagement of activating
receptors (Eidson et al., 2011). Comparisons of canonical
and adaptive NK cells also revealed regulation of additional
BTB-ZF transcription factors. ZBTB38 was hypomethylated
and transcriptionally upregulated in adaptive NK cells. ZBTB38
binds methylated CpG sites within DNA and participates in
negative regulation of apoptosis (Oikawa et al., 2008). Zbtb32
is critical for proliferation of mouse adaptive NK cells (Beaulieu
et al., 2014). Although ZBTB32 transcript levels were similar
between adaptive and canonical human NK cells in our
array analysis, ZBTB32 appeared poised through TSS hypome-
thylation. Thus, these BTB-ZF proteins might orchestrate
genome-wide epigenetic responses of NK cells to environmental
stimuli.
We have delineated a functional divergence among human NK
cell subsets, providing evidence for a critical role of FcεRg and
EAT-2, linked to NCR- and SLAMFR-mediated recognition,
respectively, in regulatory killing of activated immune cells. A
lack of FcεRg or EAT-2 in NK cells might reduce tonic activating
signaling instigated by hematopoietic NCR and SLAMFR li-
gands. Thus, in adaptive NK cells, IFNG and TNF loci can be
relaxed, as evidenced by DNA hypomethylation, reducing the
signaling threshold for induction of cytokine expression upon
target cell recognition by other activating receptors. NK cell re-
sponses to activated T cells were not attenuated by the lack of
SYK. In fact, the lack of SYK correlated with an increased capac-
ity of NK cells to produce IFN-g and TNF. SYK– cells that rely on
ZAP-70 for ITAM-coupled receptor activation should receive
less tonic NK cell signals (Hesslein et al., 2011; Kolanus et al.,
1993). Thus, our data suggest that the lack of B and myeloid
cell-related signaling protein expression can reduce tonic
signaling and thereby facilitate stronger effector responses by
adaptive NK cells specialized for recognition of infected cells.
Hypothetically, high frequencies of adaptive NK cells might
also bias for enhanced adaptive responses by sparing activated
immune cells that express stress ligands, which otherwise can
be killed by canonical regulatory NK cells. In addition, PLZF
might maintain IL12RB2 and IL18RAP expression (Gleimer
et al., 2012; Mathew et al., 2012). Expression of these IL-12
and IL-18 receptor subunits was diminished in adaptive NK cells,
resulting in unresponsiveness. From a functional perspective,
‘‘canonical’’ NK cells could be termed ‘‘immunoregulatory,’’ re-
flecting their capacity to uphold immune homeostasis and con-
trasting ‘‘adaptive’’ NK cells specialized for immunosurveillance
of infected cells andwith the capacity to survive and proliferate in
inflammatory conditions.
We find long-term persistence of NK cells lacking FcεRg, EAT-
2, and SYK after HCMV reactivation in HCT recipients. Although
reactivation of latent HCMV is associated with an increased risk
of non-relapse-relatedmorbidity andmortality, it is also indepen-
dently associated with substantial reductions in the rates of leu-
kemia relapse in patients with acutemyelogenous leukemia early
after transplantation (Green et al., 2013; Ito et al., 2013). It is
possible that adaptive NK cells that arise in response to HCMV
reactivation promote a graft-versus-leukemia effect directly454 Immunity 42, 443–456, March 17, 2015 ª2015 Elsevier Inc.through tumor immunosurveillance or indirectly through reduced
killing of activated T cells. Therefore, adaptive NK cells have the
potential to be therapeutically beneficial in both controlling
HCMV infections and treating patients with hematological
malignancies.
EXPERIMENTAL PROCEDURES
Cells
This study was approved by The Regional Ethical Review Board in Stockholm.
Healthy controls were recruited from the Karolinska University Hospital blood
bank. PBMCs were isolated from healthy donors by density gradient centrifu-
gation and resuspended in complete medium (RPMI 1640 supplemented with
10% fetal bovine serum [FBS], L-glutamine; all Hyclone). The K562 and P815
cell lines (both ATCC) were maintained in complete medium. All mammalian
cells were maintained in, and functional assays performed at, 37C with 5%
(v/v) CO2. Insect cells were cultured in Schneider’s Drosophila Medium (Invi-
trogen) supplemented with 10% FBS and L-glutamine at 28C.
Hematopoietic Cell Transplant Patient Samples
Informed consent and approval from the University of Minnesota Institutional
Review Board was obtained for sample collection. All patients received he-
matopoietic progenitor cells from umbilical cord blood donors. Patients
were monitored weekly for HCMV reactivation by quantitative PCR, and
HCMV viremia (>100 copies/ml) was treated with an 8-week course of ganci-
clovir. PBMCs collected from patients at each time point were isolated by
density centrifugation and cryopreserved. The average percentage of donor-
derived NK cells across all recipients regardless of HCMV status was
99.3% ± 4.4% at 3 months, 99.9% ± 0.9% at 6 months, and 99.4% ± 2.3%
at 1 year.
Flow Cytometry
Fluorochrome-conjugated antibodies were purchased from BD Bioscience,
Beckman Coulter, BioLegend, eBioscience, Invitrogen, R&D Systems, or BD
Biosciences, as specified in the Supplemental Experimental Procedures. For
phenotypic analyses, PBMCs were surface stained with indicated antibodies
and a fixable dead cell stain (Invitrogen) in FACS buffer (PBS supplemented
with 2% FBS and 2 mM EDTA). Cells were thereafter fixed in 2% formalde-
hyde, permeabilized in 0.05% Triton X-100, and stained intracellularly. Details
on functional flow cytometry assays, including co-incubations with autologous
activated T cells or HCMV-infected monocytes, are provided in the Supple-
mental Experimental Procedures. Flow cytometry data were acquired on an
LSR Fortessa instrument (BD Biosciences) and analyzed with FlowJo
(v.9.7.4, Tree Star). Multidimensional flow cytometry analysis via Barnes-Hut
t-distributed stochastic neighbor embedding is described in the Supplemental
Experimental Procedures.
Bisulfite Sequencing and Genome-wide DNA Methylation Analyses
Lymphocyte subsets were sorted by flow cytometry (FACSAria II, BD Biosci-
ences), and DNA was extracted with the DNeasy Blood & Tissue Kit (QIAGEN).
The EpiTect Bisulfite Kit (QIAGEN) was used to convert unmethylated
cytosines to uracils. Primers used for bisulfite sequencing are detailed in the
Supplemental Experimental Procedures. PCR products were cloned into the
TOPO-XL vector (Invitrogen) and sequenced.
For genome-wide methylation analysis, bisulfite-converted DNA was
analyzed with the Infinium HumanMethylation450 BeadChip platform (Illu-
mina). A comprehensive description of the analysis pipeline is provided in
the Supplemental Experimental Procedures.
Gene Expression Analysis
Donor PBMCs were screened for individuals where FcεRg– and PLZF– NK cell
subsets correlated with NKG2C surface expression. For the donors used in the
expression analysis, 89.3% ± 9.5% (mean ± SD) or 3.6% ± 2.6% expressed
FcεRg and 89.0% ± 9.8% or 1.7% ± 1.3% expressed PLZF of the canon-
ical CD3–CD56dimCD57+NKG2A–NKG2C– or adaptive CD3–CD56dimCD57+
NKG2A–NKG2C+ populations, respectively. Based on CD57, NKG2A, and
NKG2C expression, CD3–CD56dim NK cell subsets were sorted from four
donors into RLT buffer (QIAGEN) by flow cytometry (FACS Aria III, BD Biosci-
ences). Total RNA was isolated (RNeasy, QIAGEN). At least 100 ng of RNA
were used for sample preparation (Ambion whole-transcript expression kit
and Affymetrix whole-transcript terminal labeling kit). Samples were hybridized
to GeneChip Human Transcriptome Array 2.0 cartridges (Affymetrix).
Data conversion and quantile normalization was performed with Affymetrix
software.
Statistical Analyses
Statistics were calculated with GraphPad Prism (v.5.0).
ACCESSION NUMBERS
Raw data of resulting chips were uploaded to Gene Expression Omnibus
(GEO) database under the accession number GSE66564.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.immuni.2015.02.008.
AUTHOR CONTRIBUTIONS
H.S. did experiments, analyzed data, and developed and wrote the manu-
script; F.C. did experiments, analyzed data, and developed and wrote the
manuscript; B.T. performed bioinformatical analyses of DNA methylation
and gene expression data and contributed to drafting the manuscript; J.T.
developed multivariate flow cytometry data analyses and contributed to draft-
ing themanuscript; V.B. did flow cytometry with staining for KIRs and analyzed
data; T.D.H. sorted cells for gene expression analyses, performed phospho-
STAT4 experiments, and analyzed data; H.H. analyzed data and provided
advice; S.C.C.C. assisted in biobanking and performed experiments; B.F. per-
formed flow cytometry on transplant recipient samples and analyzed data;
K.M. assisted in biobanking and performed experiments; S.L. provided access
to blood donor samples; M.S. genotyped donors; K.-J.M. supervised research
and provided advice; H.-G.L. supervised research and data analysis and pro-
vided advice; J.S.M. supervised research and data analysis and provided
advice; Y.T.B. coordinated research efforts, supervised research work and
data analysis, and prepared the manuscript; and all authors discussed and
revised the manuscript.
ACKNOWLEDGMENTS
This work was supported by the European Research Council under the Euro-
pean Union’s Seventh Framework Programme (FP/2007-2013)/ERC Grant
Agreement no. 311335, Swedish Research Council, Swedish Foundation for
Strategic Research, Swedish Cancer Foundation, Swedish Children’s Cancer
Foundation, Knut and Alice Wallenberg Foundation, the Karolinska Institute
Research Foundation, the Frontiers in Biomedical Research Fellowship, and
University of Minnesota T32 Haematology Training Grant. We thank Marcus
Holm, Uppsala Multidisciplinary Center for Advanced Computational Science,
for writing data pre- and post-processing code enabling usage of Barnes-Hut
t-SNE, the Karolinska Institutet Bioinformatics and Expression Analysis core
facility, supported by the Karolinska Institiutet Board of Research and the Kar-
olinska Hospital Research Committee, for assistance with arrays, and Iyadh
Douagi for assistance with cell sorting.
Received: July 1, 2014
Revised: December 31, 2014
Accepted: February 20, 2015
Published: March 17, 2015
REFERENCES
Anfossi, N., Andre´, P., Guia, S., Falk, C.S., Roetynck, S., Stewart, C.A., Breso,
V., Frassati, C., Reviron, D., Middleton, D., et al. (2006). Human NK cell educa-
tion by inhibitory receptors for MHC class I. Immunity 25, 331–342.Arsenio, J., Kakaradov, B., Metz, P.J., Kim, S.H., Yeo, G.W., and Chang, J.T.
(2014). Early specification of CD8+ T lymphocyte fates during adaptive immu-
nity revealed by single-cell gene-expression analyses. Nat. Immunol. 15,
365–372.
Beaulieu, A.M., Zawislak, C.L., Nakayama, T., and Sun, J.C. (2014). The tran-
scription factor Zbtb32 controls the proliferative burst of virus-specific natural
killer cells responding to infection. Nat. Immunol. 15, 546–553.
Be´ziat, V., Liu, L.L., Malmberg, J.A., Ivarsson, M.A., Sohlberg, E., Bjo¨rklund,
A.T., Retie`re, C., Sverremark-Ekstro¨m, E., Traherne, J., Ljungman, P., et al.
(2013). NK cell responses to cytomegalovirus infection lead to stable imprints
in the human KIR repertoire and involve activating KIRs. Blood 121, 2678–
2688.
Bezman, N.A., Kim, C.C., Sun, J.C., Min-Oo, G., Hendricks, D.W., Kamimura,
Y., Best, J.A., Goldrath, A.W., Lanier, L.L., Gautier, E.L., et al.; Immunological
Genome Project Consortium (2012). Molecular definition of the identity and
activation of natural killer cells. Nat. Immunol. 13, 1000–1009.
Biron, C.A., Byron, K.S., and Sullivan, J.L. (1989). Severe herpesvirus infec-
tions in an adolescent without natural killer cells. N. Engl. J. Med. 320,
1731–1735.
Bjo¨rkstro¨m, N.K., Riese, P., Heuts, F., Andersson, S., Fauriat, C., Ivarsson,
M.A., Bjo¨rklund, A.T., Flodstro¨m-Tullberg, M., Michae¨lsson, J., Rottenberg,
M.E., et al. (2010). Expression patterns of NKG2A, KIR, and CD57 define a pro-
cess of CD56dim NK-cell differentiation uncoupled from NK-cell education.
Blood 116, 3853–3864.
Bryceson, Y.T., March, M.E., Ljunggren, H.G., and Long, E.O. (2006).
Activation, coactivation, and costimulation of resting human natural killer cells.
Immunol. Rev. 214, 73–91.
Buchholz, V.R., Flossdorf, M., Hensel, I., Kretschmer, L., Weissbrich, B., Gra¨f,
P., Verschoor, A., Schiemann, M., Ho¨fer, T., and Busch, D.H. (2013). Disparate
individual fates compose robust CD8+ T cell immunity. Science 340, 630–635.
Caligiuri, M.A. (2008). Human natural killer cells. Blood 112, 461–469.
Cichocki, F., Miller, J.S., Anderson, S.K., and Bryceson, Y.T. (2013).
Epigenetic regulation of NK cell differentiation and effector functions.
Front. Immunol. 4, 55.
Constantinides,M.G., McDonald, B.D., Verhoef, P.A., andBendelac, A. (2014).
A committed precursor to innate lymphoid cells. Nature 508, 397–401.
Crouse, J., Bedenikovic, G., Wiesel, M., Ibberson, M., Xenarios, I., Von Laer,
D., Kalinke, U., Vivier, E., Jonjic, S., and Oxenius, A. (2014). Type I interferons
protect T cells against NK cell attack mediated by the activating receptor
NCR1. Immunity 40, 961–973.
Eidson, M., Wahlstrom, J., Beaulieu, A.M., Zaidi, B., Carsons, S.E., Crow, P.K.,
Yuan, J., Wolchok, J.D., Horsthemke, B., Wieczorek, D., and Sant’Angelo,
D.B. (2011). Altered development of NKT cells, gd T cells, CD8 T cells and
NK cells in a PLZF deficient patient. PLoS ONE 6, e24441.
Ferlazzo, G., Tsang, M.L., Moretta, L., Melioli, G., Steinman, R.M., and Mu¨nz,
C. (2002). Human dendritic cells activate resting natural killer (NK) cells and are
recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195,
343–351.
Firth, M.A., Madera, S., Beaulieu, A.M., Gasteiger, G., Castillo, E.F., Schluns,
K.S., Kubo, M., Rothman, P.B., Vivier, E., and Sun, J.C. (2013). Nfil3-indepen-
dent lineage maintenance and antiviral response of natural killer cells. J. Exp.
Med. 210, 2981–2990.
Foley, B., Cooley, S., Verneris, M.R., Pitt, M., Curtsinger, J., Luo, X., Lopez-
Verge`s, S., Lanier, L.L., Weisdorf, D., and Miller, J.S. (2012). Cytomegalovirus
reactivation after allogeneic transplantation promotes a lasting increase in
educated NKG2C+ natural killer cells with potent function. Blood 119, 2665–
2674.
Gascoyne, D.M., Long, E., Veiga-Fernandes, H., de Boer, J., Williams, O.,
Seddon, B., Coles, M., Kioussis, D., and Brady, H.J. (2009). The basic leucine
zipper transcription factor E4BP4 is essential for natural killer cell develop-
ment. Nat. Immunol. 10, 1118–1124.
Gerlach, C., Rohr, J.C., Perie´, L., van Rooij, N., van Heijst, J.W., Velds, A.,
Urbanus, J., Naik, S.H., Jacobs, H., Beltman, J.B., et al. (2013).Immunity 42, 443–456, March 17, 2015 ª2015 Elsevier Inc. 455
Heterogeneous differentiation patterns of individual CD8+ T cells. Science
340, 635–639.
Gleimer, M., von Boehmer, H., and Kreslavsky, T. (2012). PLZF controls the
expression of a limited number of genes essential for NKT cell function.
Front. Immunol. 3, 374.
Green, M.L., Leisenring, W.M., Xie, H., Walter, R.B., Mielcarek, M., Sandmaier,
B.M., Riddell, S.R., and Boeckh, M. (2013). CMV reactivation after allogeneic
HCT and relapse risk: evidence for early protection in acute myeloid leukemia.
Blood 122, 1316–1324.
Guma´, M., Angulo, A., Vilches, C., Go´mez-Lozano, N., Malats, N., and Lo´pez-
Botet, M. (2004). Imprint of human cytomegalovirus infection on the NK cell re-
ceptor repertoire. Blood 104, 3664–3671.
Hesslein, D.G., Palacios, E.H., Sun, J.C., Beilke, J.N., Watson, S.R., Weiss, A.,
and Lanier, L.L. (2011). Differential requirements for CD45 in NK-cell function
reveal distinct roles for Syk-family kinases. Blood 117, 3087–3095.
Hwang, I., Zhang, T., Scott, J.M., Kim, A.R., Lee, T., Kakarla, T., Kim, A.,
Sunwoo, J.B., and Kim, S. (2012). Identification of humanNK cells that are defi-
cient for signaling adaptor FcRg and specialized for antibody-dependent im-
mune functions. Int. Immunol. 24, 793–802.
Ito, S., Pophali, P., Co, W., Koklanaris, E.K., Superata, J., Fahle, G.A., Childs,
R., Battiwalla, M., and Barrett, A.J. (2013). CMV reactivation is associated with
a lower incidence of relapse after allo-SCT for CML. Bone Marrow Transplant.
48, 1313–1316.
Juelke, K., Killig, M., Luetke-Eversloh, M., Parente, E., Gruen, J., Morandi, B.,
Ferlazzo, G., Thiel, A., Schmitt-Knosalla, I., and Romagnani, C. (2010). CD62L
expression identifies a unique subset of polyfunctional CD56dim NK cells.
Blood 116, 1299–1307.
Khakoo, S.I., Rajalingam, R., Shum, B.P., Weidenbach, K., Flodin, L., Muir,
D.G., Canavez, F., Cooper, S.L., Valiante, N.M., Lanier, L.L., and Parham, P.
(2000). Rapid evolution of NK cell receptor systems demonstrated by compar-
ison of chimpanzees and humans. Immunity 12, 687–698.
Kolanus, W., Romeo, C., and Seed, B. (1993). T cell activation by clustered
tyrosine kinases. Cell 74, 171–183.
Kovalovsky, D., Uche, O.U., Eladad, S., Hobbs, R.M., Yi, W., Alonzo, E., Chua,
K., Eidson, M., Kim, H.J., Im, J.S., et al. (2008). The BTB-zinc finger transcrip-
tional regulator PLZF controls the development of invariant natural killer T cell
effector functions. Nat. Immunol. 9, 1055–1064.
Kreslavsky, T., Savage, A.K., Hobbs, R., Gounari, F., Bronson, R., Pereira, P.,
Pandolfi, P.P., Bendelac, A., and von Boehmer, H. (2009). TCR-inducible PLZF
transcription factor required for innate phenotype of a subset of gammadelta
T cells with restricted TCR diversity. Proc. Natl. Acad. Sci. USA 106, 12453–
12458.
Kuijpers, T.W., Baars, P.A., Dantin, C., van den Burg, M., van Lier, R.A., and
Roosnek, E. (2008). Human NK cells can control CMV infection in the absence
of T cells. Blood 112, 914–915.
Lee, S.U., and Maeda, T. (2012). POK/ZBTB proteins: an emerging family of
proteins that regulate lymphoid development and function. Immunol. Rev.
247, 107–119.
Long, E.O., Kim, H.S., Liu, D., Peterson, M.E., and Rajagopalan, S. (2013).
Controlling natural killer cell responses: integration of signals for activation
and inhibition. Annu. Rev. Immunol. 31, 227–258.
Lopez-Verge`s, S., Milush, J.M., Schwartz, B.S., Pando, M.J., Jarjoura, J.,
York, V.A., Houchins, J.P., Miller, S., Kang, S.M., Norris, P.J., et al. (2011).456 Immunity 42, 443–456, March 17, 2015 ª2015 Elsevier Inc.Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute
human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 108, 14725–
14732.
Mathew, R., Seiler, M.P., Scanlon, S.T., Mao, A.P., Constantinides, M.G.,
Bertozzi-Villa, C., Singer, J.D., and Bendelac, A. (2012). BTB-ZF factors recruit
the E3 ligase cullin 3 to regulate lymphoid effector programs. Nature 491,
618–621.
Oikawa, Y., Matsuda, E., Nishii, T., Ishida, Y., and Kawaichi, M. (2008). Down-
regulation of CIBZ, a novel substrate of caspase-3, induces apoptosis. J. Biol.
Chem. 283, 14242–14247.
Puszyk, W., Down, T., Grimwade, D., Chomienne, C., Oakey, R.J., Solomon,
E., and Guidez, F. (2013). The epigenetic regulator PLZF represses L1 retro-
transposition in germ and progenitor cells. EMBO J. 32, 1941–1952.
Rook, A.H. (1988). Interactions of cytomegalovirus with the human immune
system. Rev. Infect. Dis. 10 (3), S460–S467.
Savage, A.K., Constantinides, M.G., Han, J., Picard, D., Martin, E., Li, B.,
Lantz, O., and Bendelac, A. (2008). The transcription factor PLZF directs the
effector program of the NKT cell lineage. Immunity 29, 391–403.
Scharer, C.D., Barwick, B.G., Youngblood, B.A., Ahmed, R., and Boss, J.M.
(2013). Global DNA methylation remodeling accompanies CD8 T cell effector
function. J. Immunol. 191, 3419–3429.
Stemberger, C., Huster, K.M., Koffler, M., Anderl, F., Schiemann, M., Wagner,
H., and Busch, D.H. (2007). A single naive CD8+ T cell precursor can develop
into diverse effector and memory subsets. Immunity 27, 985–997.
Sun, J.C., Beilke, J.N., and Lanier, L.L. (2009). Adaptive immune features of
natural killer cells. Nature 457, 557–561.
Toyoda, S., Kawaguchi, M., Kobayashi, T., Tarusawa, E., Toyama, T., Okano,
M., Oda, M., Nakauchi, H., Yoshimura, Y., Sanbo, M., et al. (2014).
Developmental epigenetic modification regulates stochastic expression of
clustered protocadherin genes, generating single neuron diversity. Neuron
82, 94–108.
Valiante, N.M., Uhrberg, M., Shilling, H.G., Lienert-Weidenbach, K., Arnett,
K.L., D’Andrea, A., Phillips, J.H., Lanier, L.L., and Parham, P. (1997).
Functionally and structurally distinct NK cell receptor repertoires in the periph-
eral blood of two human donors. Immunity 7, 739–751.
Vivier, E., Raulet, D.H., Moretta, A., Caligiuri, M.A., Zitvogel, L., Lanier, L.L.,
Yokoyama, W.M., and Ugolini, S. (2011). Innate or adaptive immunity? The
example of natural killer cells. Science 331, 44–49.
Waggoner, S.N., Cornberg, M., Selin, L.K., and Welsh, R.M. (2012). Natural
killer cells act as rheostats modulating antiviral T cells. Nature 481, 394–398.
Weiss, A., and Littman, D.R. (1994). Signal transduction by lymphocyte antigen
receptors. Cell 76, 263–274.
Xu, D., Holko, M., Sadler, A.J., Scott, B., Higashiyama, S., Berkofsky-Fessler,
W., McConnell, M.J., Pandolfi, P.P., Licht, J.D., and Williams, B.R. (2009).
Promyelocytic leukemia zinc finger protein regulates interferon-mediated
innate immunity. Immunity 30, 802–816.
Xu, H.C., Grusdat, M., Pandyra, A.A., Polz, R., Huang, J., Sharma, P., Deenen,
R., Ko¨hrer, K., Rahbar, R., Diefenbach, A., et al. (2014). Type I interferon pro-
tects antiviral CD8+ T cells from NK cell cytotoxicity. Immunity 40, 949–960.
Zhang, T., Scott, J.M., Hwang, I., and Kim, S. (2013). Cutting edge: antibody-
dependent memory-like NK cells distinguished by FcRg deficiency.
J. Immunol. 190, 1402–1406.
